Adult obesity and number of years lived with and without cardiovascular disease

Obesity

Volumn 14, Issue 7, 2006, Pages 1264-1273

  Pardo Silva, M Carolina ^a   De Laet, Chris ^a   Nusselder, Wilma J ^a   Mamun, Abdulah A ^b   Peeters, Anna ^a,c,d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

Cardiovascular disease; Life expectancy

Indexed keywords

AGING; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; COST OF ILLNESS; FEMALE; HEART INFARCTION; HUMAN; LIFE EXPECTANCY; MALE; MIDDLE AGED; MORTALITY; OBESITY; PHYSIOLOGY; RISK ASSESSMENT; RISK FACTOR; TIME;

AGING; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CEREBROVASCULAR ACCIDENT; COST OF ILLNESS; FEMALE; HUMANS; LIFE EXPECTANCY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OBESITY; OVERWEIGHT; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 33846111100     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2006.144     Document Type: Article

References (29)

1. National Task Force on the Prevention and Treatment of Obesity. Overweight, obesity, and health risk. Arch Intern Med. 2000;160:898-904.
2. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286:1195-200.
3. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76-9.
4. Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. 2002;162:1867-72.
5. Manson JE, Colditz GA, Stampfer MJ, et al. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med. 1990;322:882-9.
6. Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347:305-13.
7. Kurth T, Gaziano JM, Berger K, et al. Body mass index and the risk of stroke in men. Arch Intern Med. 2002;162:2557-62.
8. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67:968-77.
9. Kannel WB, Wilson PW, Nam BH, D'Agostino RB. Risk stratification of obesity as a coronary risk factor. Am J Cardial. 2002;90:697-701.
10. Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al Mamun A, Bonneux L. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med. 2003;138:24-32.
11. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA. 2003;289:187-93.
12. Thompson D, Edelsberg J, Colditz GA, Bird AP, Oster G. Lifetime health and economic consequences of obesity. Arch Intern Med. 1999;159:2177-83.
13. Peeters A, Bonneux L, Barendregt J, Nusselder W. Methods of estimating years of life lost due to obesity. JAMA. 2003;289:2941.
14. Visscher TL, Rissanen A, Seidell JC, et al. Obesity and unhealthy life-years in adult Finns: an empirical approach. Arch Intern Med. 2004;164:1413-20.
15. Dawber TM, G. Moore F. Epidemilogical approaches to heart disease: the Framingham Study. Am J Public Health. 1951;41:279-86.
16. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation. Geneva, Switzerland: World Health Organization; 2000.
17. Shurtleff D. Some characteristics related to the incidence of cardiovascular disease and death: Framingham study 16 years follow-up. In: Kannel WGT, ed. The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease. Washington, DC: Government Printing Office; 1971.
18. Peeters A, Mamun AA, Willekens F, Bonneux L. A cardiovascular life history. A life course analysis of the original Framingham Heart Study cohort. Eur Heart J. 2002;23:458-66.
19. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-71.
20. National Cholesterol Education Program. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.
21. Grambsch PTT. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81:515-26.
22. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 1982;69:239-41.
23. STATA, version 7.0. College Station, TX: Statacorp LP; 2001.
24. S-Plus, Professional Edition, Version 6.0.2 Release 1 for Windows. Seattle, WA: Mathsoft, Inc.; 2001.
25. Seidell JC, Visscher TL, Hoogeveen RT. Overweight and obesity in the mortality rate data: current evidence and research issues. Med Sci Sports Exerc. 1999;31(11 Suppl):S597-601.
26. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348:1625-38.
27. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med. 1999;341:1097-105.
28. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation. Geneva, Switzerland: World Health Organization Tech Rep Ser, 2000; pp. i-xii, 1-253, 894.
29. Edwards A, Elwyn G, Mulley A. Explaining risks: turning numerical data into meaningful pictures. BMJ. 2002;324:827-30.